Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01795456 · ClinicalTrials.gov registry record
Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 7
- Enrollment target
NCT01795456 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 7 participants.
The verdict
NCT01795456 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of contrast enhanced carotid ultrasound to serve as an indicator of disease activity in patients with Takayasu's arteritis or Giant Cell arteritis and to determine if patients with active arteritis have a thickening of their blood vessel walls compared to healthy people of the same age and gender.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01795456
The ClinicalTrials.gov registry entry for NCT01795456 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01795456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01795456 about?
NCT01795456 is a clinical study titled "Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis". The purpose of this study is to evaluate the ability of contrast enhanced carotid ultrasound to serve as an indicator of disease activity in patients with Takayasu's arteritis or Giant Cell arteritis and to determine if patients with active arteritis have a thickening of their blood vessel walls com...
What is the current status of trial NCT01795456?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-08. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01795456?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.